Latest Strategy Changes News

Kali Metals Limited has successfully raised approximately A$7 million through a Tranche 1 Placement, issuing over 38 million new shares at 18 cents each. This capital injection marks a significant step in the company’s funding strategy.

Pureprofile Limited has agreed to acquire CRNRSTONE, an established Australian qualitative research firm, for $700,000 in cash, enhancing its market research capabilities and expected to be earnings accretive from year one.

Alma Metals has revealed a robust 2 million tonne copper resource at its Briggs Project in Central Queensland, setting the stage for a major drilling campaign and pre-feasibility study amid a tightening global copper market.

TZ Limited clarifies its debt repayment timeline and progresses trade finance arrangements to support growing Microsoft-related sales, while highlighting its innovative AI-driven security technology.

Whitefield Income Limited reported a robust half-year profit surge and a significant capital raise, maintaining steady dividends amid a cautiously optimistic economic outlook.

Cauldron Energy has reported a significant 32% increase in uranium resources at its Yanrey Uranium Project, highlighted by a maiden Mineral Resource Estimate for Manyingee North and an upgraded resource at Manyingee South.

Hydralyte USA has implemented targeted headcount reductions saving around US$25,000 monthly and completed manufacturing runs to resolve supply shortages, replenishing inventory with key distributors to support near-term sales growth.

Kinatico Ltd reports robust H1 FY26 results, driven by a 49.5% surge in SaaS revenue and the launch of its AI-powered Kinatico Compliance platform, significantly broadening its addressable market.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.

AMCIL and AFIC announce a major leadership transition as long-serving CEO Mark Freeman retires, with Alison Gibson appointed to succeed him in July 2026.

Mark Freeman, the long-serving CEO of Mirrabooka Investments and AFIC, is set to retire at the end of 2026, with Alison Gibson appointed as his successor. Gibson’s return marks a significant leadership transition for these major listed investment companies.